Absence of association of metabolic syndrome with PPARGC1A, PPARG and UCP1 gene polymorphisms in Asian Indians

Metabolic Syndrome and Related Disorders

Volumn 5, Issue 2, 2007, Pages 153-162

  Vimaleswaran, K S ^a   Radha, V ^a   Deepa, R ^a   Mohan, V ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THREONINE; UNCOUPLING PROTEIN 1;

ADULT; AGED; ARTICLE; ASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; INDIAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 34250762632     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2006.0032     Document Type: Article

References (31)

1. Reaven GM. A syndrome of resistance to insulin stimulated uptake (Syndrome X). Definitions and implications. Cardiovasc Risk Factors 1993;3:2-11.
2. Mather HM, Keen H. The Southall diabetes survey: prevalence of known diabetes in Asians and Europeans. Br Med J 1985;291:1081-1084.
3. Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia 1997;40:232-237.
4. King H, Auberti RE, Herman WH. Global burden of diabetes. 1995-2025 - Prevalence, numerical estimates and projections. Diabetes Care 1998;2:1414-1431.
5. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999;84:2329-2335.
6. Joshi SR. Metabolic Syndrome - Emerging clusters of the Indian phenotype. J Assoc Physicians India 2003;51: 445-446.
7. Brooks SL, Rothwell NJ, Stock MJ, Goodbody AE, Trayhurn P. Increased proton conductance pathway in brown adipose tissue mitochondria of rats exhibiting diet-induced thermogenesis. Nature 1980;286: 274-276.
8. Sears IB, MacGinnitie MA, Kovacs LG, Graves RA. Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma. Mol Cell Biol 1996;16:3410-3419.
9. Vimaleswaran KS, Radha V, Ghosh S, Majumder PP, Sathish babu HN, Rao MRS, Deepa R , Mohan V. Peroxisome Proliferator Activated Receptor Gamma Coactivator-1 (PGC-1) gene polymorphisms and their relationship to type 2 diabetes in Asian Indians. Diabet Med 2005;22:1516-1521.
10. Vimaleswaran KS, Radha V, Anjana M, Deepa R, Ghosh S, Saurabh G, Majumder PP, Rao MRS, Mohan V. Effects of polymorphisms in the PPARGC1A Gene on body fat distribution in Asian Indians. Int J Obes (Lond) 2006;30:884-91.
11. Meirhaeghe A, Cottel D, Amouyel P, Dallongeville J. Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women. Diabetes 2005;54:3043-3048.
12. Frederiksen L, Brodbaek K, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA. Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab 2002;87:3989-3992.
13. Forga L, Corbalan M, Marti A, Fuentes C, Martinez-Gonzalez MA, Martinez A. Influence of the polymorphism 3826 A → G in the UCP1 gene on the components of metabolic syndrome. An Sist Sanit Navar 2003;26:231-236.
14. Deepa M, Pradeepa R, Rema M, Anjana Mohan, Deepa R, Shanthirani S, Mohan V. The Chennai Urban Rural Epidemiology Study (CURES) - Study design and Methodology (Urban Component) (CURES - 1). J Assoc Physicians India. 2003;51:863-870.
15. The Asia Pacific perspective: Redefining obesity and its treatment. Regional office for the western Pacific of the World Health Organization. World Health Organization, International association for the study of Obesity and International Obesity Task force. Health Communications Australia Pvt Limited. 2000;22-29.
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
18. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442-443.
19. Deepa R, Shanthirani CS, Premalatha G, Sastry NG, Mohan V. Prevalence of insulin resistance syndrome in south Indian population - The Chennai Urban Population Study (CUPS No. 7). Ind J Med Res 2002;115: 118-127.
20. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1982:149-151.
21. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997;241:270-274.
22. McLachlan GJ, Krishnan T. The EM algorithm and extensions: Wiley series in probability and statistics. New York: John Wiley and Sons, 1997.
23. Radha V, Vimaleswaran KS, Babu HNS, Abate N, Chandalia M, Satija P, Grundy SM, Ghosh S, Majumder PP, Deepa R, Rao MRS, Mohan V. Role of Genetic polymorphism peroxisome proliferator-Activated Receptor-2 Pro12Ala on ethnic Susceptibility to Diabetes in South- Asian and Caucasian Subjects: Evidence for heterogeneity. Diabetes Care 2006;29:1046-1051.
24. Doney A, Fischer B, Frew D, Cumming A, Flavell DM, World M, Montgomery HE, Boyle D, Morris A, Palmer CN. Haplotype analysis of the PPAR gamma Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet 2002;3:21.
25. Mori H, Okazawa H, Iwamoto K, Maeda E, Hashiramoto M, Kasuga M. A polymorphism in the 5′ untranslated region and a Met229→ Leu variant in exon 5 of the human UCP1 gene are associated with susceptibility to type II diabetes mellitus. Diabetologia 2001;44:373-376.
26. Ambye L, Rasmussen S, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC- 1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res Clin Pract 2005; 67:175-179.
27. Sookoian S, Garcia SI, Porto PI, Dieuzeide G, Gonzalez CD, Pirola CJ. Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents. J Mol Endocrinol 2005;35:373-380.
28. Kolaskar AS, Joshi B, Reddy BV. Contextual constraints in the choice of synonymous codons. Indian J Biochem Biophys 1995;32:417-423.
29. Sarzynska J, Nilsson L, Kulinski T. Effects of base substitutions in an RNA hairpin from molecular dynamics and free energy simulations. Biophys J. 2003;85: 3445-3459.
30. Basu A, Mukherjee N, Roy S, Sengupta S, Banerjee S, Chakraborty M, Dey B, Roy M, Roy B, Bhattacharyya NP, Roychudhury S, Majumder PP. Ethnic India: a genomic view, with special reference to peopling and structure. Genome Res 2003;13:2277-2290.
31. Devlin B, Roeder K, Wasserman L: Genomic control, a new approach to genetic-based association studies. Theor Popul Biol. 2001;60:155-166.